Neuraxpharm and Dizlin Pharmaceuticals Announce Global Strategic Co-Development Agreement Bringing Next-Generation Drug-Device Therapy to Patients with Advanced Parkinson's Disease

Neuraxpharm Germany Sweden United States of America United Kingdom

[Accessed 01 July 2025.]

View original content:https://www.prnewswire.co.uk/news-releases/neuraxpharm-and-dizlin-pharmaceuticals-announce-global-strategic-co-development-agreement-bringing-next-generation-drug-device-therapy-to-patients-with-advanced-parkinsons-disease-302499103.html